300060117312

MERCK SHARP DOHME 30 Tablets 10mg Merck & Co, Inc. Singulair

AI Insights

The barcode 300060117312 corresponds to Merck Sharp Dohme's Singulair, which is a medication primarily utilized for the management of respiratory conditions, including asthma and chronic obstructive pulmonary disease (COPD). The product is available in a 30-tablet pack containing 10mg of the active ingredient, montelukast.

Montelukast is classified as a leukotriene receptor antagonist. It functions by inhibiting the action of leukotrienes, which are substances in the body that can lead to inflammation, bronchoconstriction, and mucus production in the airways. This effect helps to alleviate the symptoms associated with asthma and to reduce the frequency of asthma attacks.

The typical recommended dosage for adults is 10mg, to be taken once daily. However, it is crucial to note that dosage may vary based on individual patient needs and underlying health conditions.

While Singulair is generally well-tolerated, some potential side effects may occur. Commonly reported side effects include:

  • Headache
  • Fatigue
  • Stomach pain
  • Diarrhea
  • Nausea

In more rare instances, Singulair has been associated with serious side effects, including but not limited to:

  • Increased risk of asthma exacerbations
  • Skin reactions, such as Stevens-Johnson syndrome
  • Seizures
  • Liver damage

A health-related disclaimer notice exists for Singulair, emphasizing the importance of using the medication as directed and advising patients to consult their healthcare provider if they experience any adverse effects or have questions about their treatment.

Pricing for Singulair can vary widely due to factors such as pharmacy location and the presence of insurance coverage. Approximate price ranges for the product are:

  • 10mg tablets: $15-$30 per pack (30-count)
  • 5mg tablets: $20-$40 per pack (30-count)

It is always advisable for patients to consult with a healthcare professional before initiating any medication, including Singulair, to discuss the potential risks, benefits, and alternative treatment options.

バーコード詳細
出典:
製造者コード:
製品コード:
検索統計
今日:
0
先週:
5
先月:
24
総検索数:
131

コメント 0

まだコメントはありません。最初のコメントを投稿しましょう!

顧客満足度

この製品情報は役に立ちましたか?

0 / 0

この製品をおすすめしますか?

0 / 0
上位 10 か国
Vietnam 2
Unknown 12
United States 74
United Kingdom 13
Singapore 3
Germany 4
France 11
Finland 4
Canada 7
Bangladesh 1